Ginkgo Bioworks (Soaring Eagle Acquisition) ^{Priced, Nasdaq: DNA}

We are a blank check company. Our efforts to identify a prospective initial business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify and combine with a business or businesses that can benefit from our management team’s established global relationships and operating experience. Our management team has extensive experience in identifying and executing strategic investments globally and has done so successfully in a number of sectors, including media and entertainment. Our amended and restated memorandum and articles of association prohibit us from effectuating a business combination solely with another blank check company or similar company with nominal operations. The members of our management team, including Harry E. Sloan, our Chief Executive Officer and Chairman, and Eli Baker, our President and Chief Financial Officer, have extensive experience with special purpose acquisition companies and consummating business combinations.